2015 Fiscal Year Final Research Report
Development of electric magnetic field combination therapy in lung cancer chemotherapy.
| Project/Area Number |
25350578
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Medical systems
|
|---|
| Research Institution | Kanazawa Medical University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KAKIKAWA Makiko 金沢大学, 電子情報学系, 助教 (10359713)
YAMADA Sotoshi 金沢大学, 環日本海域環境研究センター, 連携研究員 (80019786)
|
|---|
| Project Period (FY) |
2013-04-01 – 2016-03-31
|
| Keywords | 新規医療技術開発 |
|---|
| Outline of Final Research Achievements |
Our research aim is to reduce of side effects and drug resistance cells onset using anticancer drugs in cancer chemotherapy. We examined ability of the cytotoxicity reaction augmentation by an anticancer drug and extremely low frequency - electric magnetic field (ELF-EMF) exposure combination using human lung cancer cell line. Cisplatin is an anticancer drug used in lung cancer chemotherapy. Augmentation of cisplatin cytotoxicity reaction using ELF-EMF exposure combination was observed in a blood cisplatin levels range to be given by ordinary chemotherapy.
Our results indicates that likelihood of development of the minimally invasive new medical technology.
|
| Free Research Field |
分子生物学
|
